Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users

Social Science and Medicine

Volumn 66, Issue 2, 2008, Pages 211-220

  Cox, Joseph ^a,b,c   De, Prithwish ^a   Morissette, Carole ^b   Tremblay, Claude ^b   Stephenson, Randolph ^c   Allard, Robert ^a   Graves, Lisa ^c   Roy, Élise ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Montreal Public Health Department   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Canada; Hepatitis C; Injection drug use; Knowledge; Risk perceptions; Self efficacy

Indexed keywords

DRUG USER; HEALTH RISK; HEPATITIS; INFECTIOUS DISEASE; KNOWLEDGE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AWARENESS; CAUCASIAN; DRUG ABUSE; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COUNSELING; PATIENT EDUCATION; POPULATION RISK; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; SOCIAL PSYCHOLOGY; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; CANADA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEEDLE SHARING; PSYCHOLOGY; RISK REDUCTION BEHAVIOR; RISK-TAKING; SELF EFFICACY; SUBSTANCE ABUSE, INTRAVENOUS;

CANADA; MONTREAL; NORTH AMERICA; QUEBEC [CANADA];

HEPATITIS C VIRUS;

EID: 36849024348     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2007.08.022     Document Type: Article

References (22)

1. Abdi H. Factor rotations in factor analyses. In: Lewis-Beck M., Bryman A., and Futing T. (Eds). Encyclopedia for research methods for the social sciences (2003), Sage, Thousand Oaks (CA) 792-795
2. Carey J., Perlman D.C., Friedmann P., Kaplan W.M., Nugent A., Deutscher M., et al. Knowledge of hepatitis among active drug injectors at a syringe exchange program. Journal of Substance Abuse Treatment 29 1 (2005) 47-53
3. Catania J.A., Kegeles S.M., and Coates T.J. Towards an understanding of risk behavior: An AIDS risk reduction model (ARRM). Health Education Quarterly 17 1 (1990) 53-72
4. Celentano D.D., Cohn S., Davis R.O., and Vlahov D. Self-efficacy estimates for drug use practices predict risk reduction among injection drug users. Journal of Urban Health 79 2 (2002) 245-256
5. Connors M.M. Risk perception, risk taking and risk management among intravenous drug users: Implications for AIDS prevention. Social Science & Medicine 34 6 (1992) 591-601
6. Cox, J., Stephenson, R., Morissette, C., Roy, E., Graves, L., Allard, R., et al. (2002). Development of a questionnaire on hepatitis C-related knowledge, attitudes and behaviours of injection drug users. Poster Presentation. 1st International Conference on Inner City Health, Toronto, Canada. Journal of Urban Health, Suppl.1; 79(4): S99.
7. Davis M., Rhodes T., and Martin A. Preventing hepatitis C: 'Common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs. Social Science & Medicine 59 9 (2004) 1807-1818
8. Dowling-Guyer S., Johnson M.E., Fisher D.G., Needle R., Watters J., Anderson M., et al. Reliability of drug user's self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment 1 (1994) 383-392
9. Fry C.L., and Lintzeris N. Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction 98 2 (2003) 171-178
10. Grau L.E., Bluthenthal R.N., Marshall P., Singer M., and Heimer R. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior 9 4 (2005) 495-504
11. Hartel D.M., Schoenbaum E.E., Selwyn P.A., Friedland G.H., Klein R.S., and Drucker E. Patterns of heroin, cocaine and speedball injection among Bronx (USA) methadone maintenance patients: 1978-1988. Addiction Research 8 (1997) 394-404
12. Heimer R., Clair S., Grau L.E., Bluthenthal R.N., Marshall P.A., and Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction 97 10 (2002) 1277-1287
13. Hosmer Jr. D.W., and Lemeshow S. Applied logistic regression (1989), Wiley, New York
14. Kang S.Y., Deren S., Andia J., Colon H.M., and Robles R. Effects of changes in perceived self-efficacy on HIV risk behaviors over time. Addictive Behavior 29 3 (2004) 567-574
15. Kline A., and Strickler J. Perceptions of risk for AIDS among women in drug treatment. Health Psychology 12 4 (1993) 313-323
16. Longshore D., and Anglin M.D. Intentions to share injection paraphernalia: An empirical test of the AIDS Risk Reduction Model among injection drug users. International Journal of the Addictions 30 3 (1995) 305-321
17. Longshore D., Stein J.A., and Anglin M.D. Psychosocial antecedents of needle/syringe disinfection by drug users: A theory-based prospective analysis. AIDS Education and Prevention 9 5 (1997) 442-459
18. Longshore D., Stein J.A., and Conner B.T. Psychosocial antecedents of injection risk reduction: A multivariate analysis. AIDS Education and Prevention 16 4 (2004) 353-366
19. Rhodes T., Davis M., and Judd A. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction 99 5 (2004) 621-633
20. Roy E., Alary M., Morissette C., Leclerc P., Bourdreau J.-F., Parent R., et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. International Journal of STD & AIDS 18 1 (2007) 23-27
21. Roy E., Lemire N., Haley N., Boivin J.-F., Frappier J.Y., and Claessens C. Injection drug use among street youth: A dynamic process. Canadian Journal of Public Health 89 4 (1998) 239-240
22. Samuels J.F., Vlahov D., Anthony J.C., and Chaisson R.E. Measurement of HIV risk behaviors among intravenous drug users. British Journal of Addiction 87 3 (1992) 417-428